Do analysts rate RDGT or COSM?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ridgetech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Cosmos Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation and earnings, RDGT or COSM?

Ridgetech has higher revenue and earnings than Cosmos Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ridgetech $132.16M 0.03 -$1.25M N/A N/A Cosmos Health $65.27M 0.35 -$19.15M -$0.64 N/A

Do analysts rate RDGT or HKPD?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ridgetech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Hong Kong Pharma Digital Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger earnings & valuation, RDGT or HKPD?

Hong Kong Pharma Digital Technology has lower revenue, but higher earnings than Ridgetech. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ridgetech $132.16M 0.03 -$1.25M N/A N/A Hong Kong Pharma Digital Technology $13.43M 0.28 -$1.14M N/A N/A

Is RDGT or HKPD more profitable?

Company Net Margins Return on Equity Return on Assets Ridgetech N/A N/A N/A Hong Kong Pharma Digital Technology N/A N/A N/A

Do analysts recommend RDGT or MEDS?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ridgetech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Wellgistics Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation & earnings, RDGT or MEDS?

Ridgetech has higher revenue and earnings than Wellgistics Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ridgetech $132.16M 0.03 -$1.25M N/A N/A Wellgistics Health $23.34M 0.13 -$101.28M -$46.13 N/A

Is RDGT or MEDS more profitable?

Ridgetech has a net margin of 0.00% compared to Wellgistics Health's net margin of -1,100.16%. Company Net Margins Return on Equity Return on Assets Ridgetech N/A N/A N/A Wellgistics Health -1,100.16% N/A -171.81%

Do analysts prefer RDGT or MCK?

McKesson has a consensus price target of $973.44, indicating a potential upside of 8.69%. Given McKesson's stronger consensus rating and higher possible upside, analysts plainly believe McKesson is more favorable than Ridgetech. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ridgetech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 McKesson 0 Sell rating(s) 4 Hold rating(s) 14 Buy rating(s) 0 Strong Buy rating(s) 2.78

Which has better earnings & valuation, RDGT or MCK?

McKesson has higher revenue and earnings than Ridgetech. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ridgetech $132.16M 0.03 -$1.25M N/A N/A McKesson $403.43B 0.26 $4.76B $37.37 23.97

Is RDGT or MCK more profitable?

McKesson has a net margin of 1.12% compared to Ridgetech's net margin of 0.00%. Ridgetech's return on equity of 0.00% beat McKesson's return on equity. Company Net Margins Return on Equity Return on Assets Ridgetech N/A N/A N/A McKesson 1.12% -253.21% 5.90%

Do analysts prefer RDGT or COR?

Cencora has a consensus price target of $370.85, suggesting a potential upside of 15.13%. Given Cencora's stronger consensus rating and higher possible upside, analysts plainly believe Cencora is more favorable than Ridgetech. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ridgetech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Cencora 0 Sell rating(s) 3 Hold rating(s) 13 Buy rating(s) 0 Strong Buy rating(s) 2.81

Which has preferable earnings & valuation, RDGT or COR?

Cencora has higher revenue and earnings than Ridgetech. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ridgetech $132.16M 0.03 -$1.25M N/A N/A Cencora $321.33B 0.19 $1.55B $13.46 23.93

Is RDGT or COR more profitable?

Cencora has a net margin of 0.79% compared to Ridgetech's net margin of 0.00%. Cencora's return on equity of 125.45% beat Ridgetech's return on equity. Company Net Margins Return on Equity Return on Assets Ridgetech N/A N/A N/A Cencora 0.79% 125.45% 4.18%

Ridgetech (RDGT) Competitors

$1.00 0.00 (0.00%)

Closing price 08/28/2026 04:00 PM Eastern

Extended Trading

$1.00 +0.00 (+0.50%)

As of 06:11 AM Eastern

Compare

RDGT vs. COSM, HKPD, MEDS, MCK, and COR

Should you buy Ridgetech stock or one of its competitors? Ridgetech's main competitors and comparable companies include Cosmos Health (COSM), Hong Kong Pharma Digital Technology (HKPD), Wellgistics Health (MEDS), McKesson (MCK), and Cencora (COR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare distributors" industry.

How does Ridgetech compare to Cosmos Health?

Ridgetech (NASDAQ:RDGT) and Cosmos Health (NASDAQ:COSM) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, risk, valuation, media sentiment, analyst recommendations, institutional ownership and dividends.

Ridgetech has a beta of -0.13, meaning that its share price is 113% less volatile than the broader market. Comparatively, Cosmos Health has a beta of 4.8, meaning that its share price is 380% more volatile than the broader market.

In the previous week, Cosmos Health had 4 more articles in the media than Ridgetech. MarketBeat recorded 6 mentions for Cosmos Health and 2 mentions for Ridgetech. Cosmos Health's average media sentiment score of 0.92 beat Ridgetech's score of 0.43 indicating that Cosmos Health is being referred to more favorably in the news media.

Company	Overall Sentiment
Ridgetech	Neutral
Cosmos Health	Positive

Ridgetech has higher revenue and earnings than Cosmos Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ridgetech	$132.16M	0.03	-$1.25M	N/A	N/A
Cosmos Health	$65.27M	0.35	-$19.15M	-$0.64	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ridgetech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Cosmos Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

45.3% of Ridgetech shares are owned by institutional investors. Comparatively, 12.6% of Cosmos Health shares are owned by institutional investors. 22.6% of Ridgetech shares are owned by insiders. Comparatively, 26.2% of Cosmos Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Ridgetech has a net margin of 0.00% compared to Cosmos Health's net margin of -33.08%. Ridgetech's return on equity of 0.00% beat Cosmos Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ridgetech	N/A	N/A	N/A
Cosmos Health	-33.08%	-56.88%	-18.03%

Summary

Ridgetech beats Cosmos Health on 6 of the 11 factors compared between the two stocks.

How does Ridgetech compare to Hong Kong Pharma Digital Technology?

Ridgetech (NASDAQ:RDGT) and Hong Kong Pharma Digital Technology (NASDAQ:HKPD) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, profitability, dividends, analyst recommendations, valuation, institutional ownership and media sentiment.

Ridgetech has a beta of -0.13, meaning that its share price is 113% less volatile than the broader market. Comparatively, Hong Kong Pharma Digital Technology has a beta of 2.33, meaning that its share price is 133% more volatile than the broader market.

In the previous week, Ridgetech had 1 more articles in the media than Hong Kong Pharma Digital Technology. MarketBeat recorded 2 mentions for Ridgetech and 1 mentions for Hong Kong Pharma Digital Technology. Hong Kong Pharma Digital Technology's average media sentiment score of 1.87 beat Ridgetech's score of 0.43 indicating that Hong Kong Pharma Digital Technology is being referred to more favorably in the news media.

Company	Overall Sentiment
Ridgetech	Neutral
Hong Kong Pharma Digital Technology	Very Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ridgetech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Hong Kong Pharma Digital Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

45.3% of Ridgetech shares are owned by institutional investors. 22.6% of Ridgetech shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Company	Net Margins	Return on Equity	Return on Assets
Ridgetech	N/A	N/A	N/A
Hong Kong Pharma Digital Technology	N/A	N/A	N/A

Hong Kong Pharma Digital Technology has lower revenue, but higher earnings than Ridgetech.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ridgetech	$132.16M	0.03	-$1.25M	N/A	N/A
Hong Kong Pharma Digital Technology	$13.43M	0.28	-$1.14M	N/A	N/A

Summary

Ridgetech and Hong Kong Pharma Digital Technology tied by winning 4 of the 8 factors compared between the two stocks.

How does Ridgetech compare to Wellgistics Health?

Ridgetech (NASDAQ:RDGT) and Wellgistics Health (NASDAQ:MEDS) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, earnings, risk, profitability, media sentiment, analyst recommendations, institutional ownership and valuation.

Ridgetech has a net margin of 0.00% compared to Wellgistics Health's net margin of -1,100.16%.

Company	Net Margins	Return on Equity	Return on Assets
Ridgetech	N/A	N/A	N/A
Wellgistics Health	-1,100.16%	N/A	-171.81%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ridgetech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Wellgistics Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

45.3% of Ridgetech shares are owned by institutional investors. Comparatively, 5.7% of Wellgistics Health shares are owned by institutional investors. 22.6% of Ridgetech shares are owned by company insiders. Comparatively, 27.0% of Wellgistics Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Ridgetech has a beta of -0.13, meaning that its stock price is 113% less volatile than the broader market. Comparatively, Wellgistics Health has a beta of -1.54, meaning that its stock price is 254% less volatile than the broader market.

In the previous week, Ridgetech had 1 more articles in the media than Wellgistics Health. MarketBeat recorded 2 mentions for Ridgetech and 1 mentions for Wellgistics Health. Wellgistics Health's average media sentiment score of 0.67 beat Ridgetech's score of 0.43 indicating that Wellgistics Health is being referred to more favorably in the news media.

Company	Overall Sentiment
Ridgetech	Neutral
Wellgistics Health	Positive

Ridgetech has higher revenue and earnings than Wellgistics Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ridgetech	$132.16M	0.03	-$1.25M	N/A	N/A
Wellgistics Health	$23.34M	0.13	-$101.28M	-$46.13	N/A

Summary

Ridgetech beats Wellgistics Health on 7 of the 10 factors compared between the two stocks.

How does Ridgetech compare to McKesson?

Ridgetech (NASDAQ:RDGT) and McKesson (NYSE:MCK) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, media sentiment, earnings, risk, institutional ownership and valuation.

45.3% of Ridgetech shares are held by institutional investors. Comparatively, 85.1% of McKesson shares are held by institutional investors. 22.6% of Ridgetech shares are held by insiders. Comparatively, 0.1% of McKesson shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

McKesson has a consensus price target of $973.44, indicating a potential upside of 8.69%. Given McKesson's stronger consensus rating and higher possible upside, analysts plainly believe McKesson is more favorable than Ridgetech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ridgetech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
McKesson	0 Sell rating(s)	4 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.78

McKesson has a net margin of 1.12% compared to Ridgetech's net margin of 0.00%. Ridgetech's return on equity of 0.00% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ridgetech	N/A	N/A	N/A
McKesson	1.12%	-253.21%	5.90%

McKesson has higher revenue and earnings than Ridgetech.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ridgetech	$132.16M	0.03	-$1.25M	N/A	N/A
McKesson	$403.43B	0.26	$4.76B	$37.37	23.97

In the previous week, McKesson had 71 more articles in the media than Ridgetech. MarketBeat recorded 73 mentions for McKesson and 2 mentions for Ridgetech. McKesson's average media sentiment score of 1.35 beat Ridgetech's score of 0.43 indicating that McKesson is being referred to more favorably in the news media.

Company	Overall Sentiment
Ridgetech	Neutral
McKesson	Positive

Ridgetech has a beta of -0.13, indicating that its share price is 113% less volatile than the broader market. Comparatively, McKesson has a beta of 0.3, indicating that its share price is 70% less volatile than the broader market.

Summary

McKesson beats Ridgetech on 12 of the 14 factors compared between the two stocks.

How does Ridgetech compare to Cencora?

Ridgetech (NASDAQ:RDGT) and Cencora (NYSE:COR) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, institutional ownership, dividends, risk, earnings, media sentiment, analyst recommendations and profitability.

Cencora has higher revenue and earnings than Ridgetech.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ridgetech	$132.16M	0.03	-$1.25M	N/A	N/A
Cencora	$321.33B	0.19	$1.55B	$13.46	23.93

In the previous week, Cencora had 33 more articles in the media than Ridgetech. MarketBeat recorded 35 mentions for Cencora and 2 mentions for Ridgetech. Cencora's average media sentiment score of 1.60 beat Ridgetech's score of 0.43 indicating that Cencora is being referred to more favorably in the news media.

Company	Overall Sentiment
Ridgetech	Neutral
Cencora	Very Positive

Ridgetech has a beta of -0.13, indicating that its stock price is 113% less volatile than the broader market. Comparatively, Cencora has a beta of 0.57, indicating that its stock price is 43% less volatile than the broader market.

Cencora has a consensus price target of $370.85, suggesting a potential upside of 15.13%. Given Cencora's stronger consensus rating and higher possible upside, analysts plainly believe Cencora is more favorable than Ridgetech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ridgetech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Cencora	0 Sell rating(s)	3 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.81

45.3% of Ridgetech shares are held by institutional investors. Comparatively, 97.5% of Cencora shares are held by institutional investors. 22.6% of Ridgetech shares are held by insiders. Comparatively, 0.4% of Cencora shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Cencora has a net margin of 0.79% compared to Ridgetech's net margin of 0.00%. Cencora's return on equity of 125.45% beat Ridgetech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ridgetech	N/A	N/A	N/A
Cencora	0.79%	125.45%	4.18%

Summary

Cencora beats Ridgetech on 13 of the 14 factors compared between the two stocks.

Get Ridgetech News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RDGT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

RDGT vs. The Competition

Export

Metric	Ridgetech	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$3.63M	$9.83B	$7.18B	$12.88B
Dividend Yield	N/A	2.56%	2.54%	11.27%
P/E Ratio	N/A	34.42	273.17	25.45
Price / Sales	0.03	5.01	638.13	103.78
Price / Cash	N/A	24.48	28.74	36.03
Price / Book	0.02	5.30	11.08	6.36
Net Income	-$1.25M	$310.63M	$3.48B	$349.79M
7 Day Performance	26.58%	-0.48%	0.21%	-0.48%
1 Month Performance	32.40%	1.18%	7.75%	4.17%
1 Year Performance	-99.46%	15.34%	24.68%	15.11%

Ridgetech Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
RDGT Ridgetech	0.7423 of 5 stars	$1.00 flat	N/A	-99.5%	$3.63M	$132.16M	N/A	980
COSM Cosmos Health	1.8714 of 5 stars	$0.21 +4.1%	N/A	-71.6%	$12.84M	$65.27M	N/A	100
HKPD Hong Kong Pharma Digital Technology	1.028 of 5 stars	$0.38 -5.2%	N/A	-77.0%	$4.15M	$13.43M	N/A	19	Gap Down
MEDS Wellgistics Health	0.0932 of 5 stars	$1.34 -1.8%	N/A	-98.4%	$4.10M	$23.34M	N/A	31	High Trading Volume
MCK McKesson	4.7557 of 5 stars	$898.06 -0.8%	$973.44 +8.4%	+30.5%	$104.70B	$403.43B	24.03	43,000	Trending News Short Interest Decrease

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:RDGT) was last updated on 8/31/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Ridgetech (RDGT) Competitors

RDGT vs. COSM, HKPD, MEDS, MCK, and COR

How does Ridgetech compare to Cosmos Health?

Summary

How does Ridgetech compare to Hong Kong Pharma Digital Technology?

Summary

How does Ridgetech compare to Wellgistics Health?

Summary

How does Ridgetech compare to McKesson?

Summary

How does Ridgetech compare to Cencora?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RDGT vs. The Competition

Ridgetech Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Ridgetech (RDGT) Competitors

RDGT vs. COSM, HKPD, MEDS, MCK, and COR

How does Ridgetech compare to Cosmos Health?

Which has more volatility and risk, RDGT or COSM?

Does the media refer more to RDGT or COSM?

Which has preferable valuation and earnings, RDGT or COSM?

Do analysts rate RDGT or COSM?

Do insiders & institutionals have more ownership in RDGT or COSM?

Is RDGT or COSM more profitable?

Summary

How does Ridgetech compare to Hong Kong Pharma Digital Technology?

Which has more risk & volatility, RDGT or HKPD?

Does the media prefer RDGT or HKPD?

Do analysts rate RDGT or HKPD?

Do insiders and institutionals have more ownership in RDGT or HKPD?

Is RDGT or HKPD more profitable?

Which has stronger earnings & valuation, RDGT or HKPD?

Summary

How does Ridgetech compare to Wellgistics Health?

Is RDGT or MEDS more profitable?

Do analysts recommend RDGT or MEDS?

Do institutionals & insiders have more ownership in RDGT or MEDS?

Which has more volatility & risk, RDGT or MEDS?

Does the media prefer RDGT or MEDS?

Which has better valuation & earnings, RDGT or MEDS?

Summary

How does Ridgetech compare to McKesson?

Do institutionals and insiders have more ownership in RDGT or MCK?

Do analysts prefer RDGT or MCK?

Is RDGT or MCK more profitable?

Which has better earnings & valuation, RDGT or MCK?

Does the media refer more to RDGT or MCK?

Which has more volatility & risk, RDGT or MCK?

Summary

How does Ridgetech compare to Cencora?

Which has preferable earnings & valuation, RDGT or COR?

Does the media prefer RDGT or COR?

Which has more volatility and risk, RDGT or COR?

Do analysts prefer RDGT or COR?

Do insiders & institutionals believe in RDGT or COR?

Is RDGT or COR more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RDGT vs. The Competition

Ridgetech Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools